Literature DB >> 3226534

The value of paramagnetic contrast agent gadolinium-DTPA in the diagnosis of pituitary adenomas.

T Nakamura1, W Schörner, R C Bittner, R Felix.   

Abstract

The purpose of this study was to assess the role of MR imaging and the paramagnetic contrast agent Gadolinium-DTPA(Gd-DTPA) in the diagnosis of pituitary macroadenomas. 44 macroadenomas were examined with MRI before and after intravenous application of Gd-DTPA. Gd-DTPA produced excellent enhancement of solid adenoma. The best contrast between adenoma and surrounding structures could be gained on post-Gd T1-weighted images. Post-Gd images were equivalent to pre-Gd images in the evaluation of supra- and infrasellar extensions of macroadenomas. Post-Gd images had advantages in the evaluation of cavernous sinus invasion by adenoma. The difference in degree of contrast enhancement between adenoma and cavernous sinus facilitated the exact evaluation of lateral extension by adenoma in 18 cases. Almost equal degree of enhancement of both structures impaired tumor-sinus contrast in 2 cases. In the other 24 cases the tumor filled the cavernous sinus completely. It is our opinion that Gd-DTPA can be used on a widespread basis because of its excellent capability to highlight and delineate pituitary adenomas.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3226534     DOI: 10.1007/bf00339687

Source DB:  PubMed          Journal:  Neuroradiology        ISSN: 0028-3940            Impact factor:   2.804


  12 in total

1.  MR imaging of pituitary adenoma: CT, clinical, and surgical correlation.

Authors:  P C Davis; J C Hoffman; T Spencer; G T Tindall; I F Braun
Journal:  AJR Am J Roentgenol       Date:  1987-04       Impact factor: 3.959

2.  Sensitivity of Gd-DTPA-enhanced MR imaging of benign extraaxial tumors.

Authors:  V M Haughton; A A Rimm; L F Czervionke; R K Breger; M E Fisher; R A Papke; L E Hendrix; C M Strother; P A Turski; A L Williams
Journal:  Radiology       Date:  1988-03       Impact factor: 11.105

3.  Gadolinium-DTPA and MR imaging of pituitary adenoma: a preliminary report.

Authors:  P C Davis; J C Hoffman; J A Malko; G T Tindall; Y Takei; L Avruch; I F Braun
Journal:  AJNR Am J Neuroradiol       Date:  1987 Sep-Oct       Impact factor: 3.825

4.  Benign extraaxial tumors: contrast enhancement with Gd-DTPA.

Authors:  R K Breger; R A Papke; K W Pojunas; V M Haughton; A L Williams; D L Daniels
Journal:  Radiology       Date:  1987-05       Impact factor: 11.105

5.  Suprasellar lesions: evaluation with MR imaging.

Authors:  M G Karnaze; K Sartor; J D Winthrop; M H Gado; F J Hodges
Journal:  Radiology       Date:  1986-10       Impact factor: 11.105

6.  Pituitary adenomas: high-resolution MR imaging at 1.5 T.

Authors:  W Kucharczyk; D O Davis; W M Kelly; G Sze; D Norman; T H Newton
Journal:  Radiology       Date:  1986-12       Impact factor: 11.105

7.  Gd-DTPA in clinical MR of the brain: 1. Intraaxial lesions.

Authors:  M Brant-Zawadzki; I Berry; L Osaki; R Brasch; J Murovic; D Norman
Journal:  AJR Am J Roentgenol       Date:  1986-12       Impact factor: 3.959

8.  Gd-DTPA in clinical MR of the brain: 2. Extraaxial lesions and normal structures.

Authors:  I Berry; M Brant-Zawadzki; L Osaki; R Brasch; J Murovic; T H Newton
Journal:  AJR Am J Roentgenol       Date:  1986-12       Impact factor: 3.959

9.  Cranial tissues: normal MR appearance after intravenous injection of Gd-DTPA.

Authors:  D P Kilgore; R K Breger; D L Daniels; K W Pojunas; A L Williams; V M Haughton
Journal:  Radiology       Date:  1986-09       Impact factor: 11.105

10.  [A multislice gradient-echo sequence for contrast medium-enhanced MR diagnosis of intracranial tumors].

Authors:  W Schörner; B Sander; W Kornmesser; M Laniado; T Nakamura; R Felix
Journal:  Rofo       Date:  1988-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.